Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484028 · ClinicalTrials.gov registry record · NA
Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 275
- Enrollment target
NCT01484028 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 275 participants.
The verdict
NCT01484028, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
Study Summary
This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.
Interventions
- DEVICE etafilcon A control lens (1DM)
- DEVICE etafilcon A with print and PVP for light eyes (EALE)
- DEVICE etafilcon A with print and PVP for dark eyes (EADE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484028
The ClinicalTrials.gov registry entry for NCT01484028 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which etafilcon A control lens (1DM) is the first listed.
NCT01484028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01484028 about?
NCT01484028 is a clinical study titled "Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens". This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.
What is the current status of trial NCT01484028?
This trial is currently completed. It is a NA study. The enrollment target is 275 participants. The study started on 2011-11. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01484028?
The interventions under investigation include: etafilcon A control lens (1DM) (DEVICE), etafilcon A with print and PVP for light eyes (EALE) (DEVICE), etafilcon A with print and PVP for dark eyes (EADE) (DEVICE).
Who is sponsoring clinical trial NCT01484028?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.